Paul Grint

Executive Chairman at Cardea Bio, Inc.

Paul Grint

Paul Grint

Executive Chairman at Cardea Bio, Inc.

Overview
Career Highlights

Cerexa, Inc.
Cardea Bio, Inc.
Armata Pharmaceuticals, Inc.

RelSci Relationships

5393

Number of Boards

16

Birthday

1958

Age

63

Contact Data
Trying to get in touch with Paul Grint? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Paul Grint likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Executive Chairman & Chief Executive Officer at aTyr Pharma, Inc.

Relationship likelihood: Strong

Managing Partner at BioScience Managers Pty Ltd

Relationship likelihood: Strong

Executive Chairman at Equillium, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at AVITA Medical, Inc.

Relationship likelihood: Strong

Managing Director at Gemini Advisors LLC

Relationship likelihood: Strong

Co-Founder at Cardea Bio, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer & Director at Arog Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Chairman of the Board & Co-Founder at Synedgen, Inc.

Relationship likelihood: Strong

Co-Founder at Synedgen, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Cardea Bio, Inc.

Relationship likelihood: Strong

Paths to Paul Grint
Potential Connections via
Relationship Science
You
Paul Grint
Executive Chairman at Cardea Bio, Inc.
Education

St Mary's is the youngest of the constituent schools of Imperial College London, founded in 1854 as part of the new hospital in Paddington. During its existence in the 1980s and 90s, it was the most popular medical school in the country, with an application to place ratio of 27:1 in 1996. St Mary's continued comparatively unmoved by the other nomadic medical schools in the area, until its merger with Imperial College in 1988, and the foundation of Imperial College School of Medicine in 1997 by the merger with Charing Cross and Westminster Medical School.

MD

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Memberships
Career History
Chief Medical Officer
Prior

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Chief Medical Officer
Prior

IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.

Chief Medical Officer
2006 - 2008

Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA.

Boards & Committees
Member, Board of Directors
2021 - Current

January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA.

Chairman
2020 - Current

Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA.

Independent Director
2020 - Current

Inhibikase Therapeutics is transforming the way pharmaceuticals attack infectious diseases. Its small molecule platform enables treatment of bacterial AND viral infectious disease through a common mechanism of action. The Company's host-targeting strategy using clinically validated targets treat infectious disease with a low likelihood of stimulating resistance. Founded in 2008 and headquartered in Atlanta, Georgia, Inhibikase Therapeutics is developing treatments for orphan indications arising from polyomaviruses, such as progressive multifocal leukoencephalopathy (PML), BK-virus associated nephropathy (PVAN), fungal and bacterial pneumonias as well as medical countermeasures for biodefense.

Member, Advisory Council
Current

Enrich society with breakthrough approaches to education and translational research in life sciences.

Member, Corporate Relations Board
Current
Director
Current

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paul Grint. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paul Grint's profile does not indicate a business or promotional relationship of any kind between RelSci and Paul Grint.